ELENOS HEALTH LIMITED

Company Registration Number:
14210779 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

ELENOS HEALTH LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

ELENOS HEALTH LIMITED

Company Information

for the Period Ended 31 July 2024




Director: Jovydas Baranauskas
Registered office: 29
Westminster Road
London
England
N9 8RA
Company Registration Number: 14210779 (England and Wales)

ELENOS HEALTH LIMITED

Directors' Report Period Ended 31 July 2024

The directors present their report with the financial statements of the company for the period ended 31 July 2024

Directors

The directors shown below have held office during the whole of the period from 01 August 2023 to 31 July 2024
Jovydas Baranauskas

This report was approved by the board of directors on 17 November 2024
And Signed On Behalf Of The Board By:

Name: Jovydas Baranauskas
Status: Director

ELENOS HEALTH LIMITED

Profit and Loss Account

for the Period Ended 31 July 2024


Notes

2024
£
13 months to
31 Jul 2023
£
Turnover 0 0
Cost of sales ( 350 ) ( 60 )
Gross Profit or (Loss) ( 350 ) ( 60 )
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 63 ) ( 3 )
Administrative Expenses ( 200 ) ( 0 )
Other operating income 0 0
Operating Profit or (Loss) ( 613 ) ( 63 )
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges ( 0 ) ( 0 )
Profit or (Loss) Before Tax ( 613 ) ( 63 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 613 ) ( 63 )

The notes form part of these financial statements

ELENOS HEALTH LIMITED

Balance sheet

As at 31 July 2024


Notes

2024
£
13 months to
31 Jul 2023
£
Fixed assets
Intangible assets: 4 0 0
Total fixed assets: 0 0
Current assets
Stocks: 0 0
Debtors: 5 450 0
Cash at bank and in hand: 2 2
Total current assets: 452 2
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 6 ( 0 ) ( 0 )
Net current assets (liabilities): 452 2
Total assets less current liabilities: 452 2
Creditors: amounts falling due after more than one year: 7 ( 0 ) ( 0 )
Provision for liabilities: ( 1 ) ( 1 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 451 1

The notes form part of these financial statements

ELENOS HEALTH LIMITED

Balance sheet continued

As at 31 July 2024


Notes

2024
£
13 months to
31 Jul 2023
£
Capital and reserves
Called up share capital: 451 1
Revaluation reserve: 8 0 0
Profit and loss account: 0 0
Shareholders funds: 451 1

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 17 November 2024
And Signed On Behalf Of The Board By:

Name: Jovydas Baranauskas
Status: Director

The notes form part of these financial statements

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    No sales have been made during this period

    Tangible fixed assets depreciation policy

    No assets were aquired during this period

    Intangible fixed assets amortisation policy

    No tangible assets of monetary value have been aqquired during this period.

    Valuation information and policy

    Stocks and work in progress are valued at the lower of cost and net realisable value, after making allowances for obsolete and slow-moving items. Cost includes all direct expenditure and overheads

    Other accounting policies

    No other accounting policies during this period

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees


    2024
    13 months to
    31 Jul 2023
    Average number of employees during the period 1 1

    No new employees

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 3. Off balance sheet disclosure

    No

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

4. Intangible assets

Other Total
Cost £ £
At 01 August 2023 - -
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 July 2024 - -
Amortisation
Amortisation at 01 August 2023 - -
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 31 July 2024 - -
Net book value
Net book value at 31 July 2024 - -
Net book value at 31 July 2023 - -

Trademark intangible asset

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

5. Debtors


2024
£
13 months to
31 Jul 2023
£
Trade debtors 120 0
Prepayments and accrued income 160 0
Other debtors 170 0
Total 450 0

Loan from director

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

6.Creditors: amounts falling due within one year note


2024
£
13 months to
31 Jul 2023
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 0 0
Other creditors 0 0
Total 0 0

no creditors

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

7.Creditors: amounts falling due after more than one year


2024
£
13 months to
31 Jul 2023
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 0 0
Total 0 0

None

ELENOS HEALTH LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2024

8. Revaluation reserve


2024
£
Balance at 01 August 2023 0
Surplus or deficit after revaluation 0
Balance at 31 July 2024 0

No value increase